Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...

Johnson & Johnson said Friday it has struck a deal to buy Atraverse Medical, an atrial fibrillation ablation device developer ...

Johnson & Johnson (NYSE:JNJ) today announced the initiation of a new trial evaluating competitive pulsed field ablation (PFA) ...

Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio.

Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's FARAPULSE™ Pulsed Field Ablation (PFA) Platform and WATCHMAN™ Left Atrial Appendage Closure (LAAC) ...

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.

Add Yahoo as a preferred source to see more of our stories on Google. KINGSPORT, Tenn. (WJHL) – On Wednesday, Holston Valley Medical Center (HVMC) successfully performed a cardiac ablation procedure ...

Medical device company Boston Scientific (NYSE:BSX) announced in Q1 CY2026, with sales up 11.6% year on year to $5.20 billion ...

- Large, Randomized Controlled ADVENT Trial Designed to Establish New Gold Standard for AF Ablation - MENLO PARK, Calif., Dec. 17, 2020/PRNewswire/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Allan Zingeler, Raju Viswanathan, PhD, and Michael Mahoney of Boston Scientific have been awarded the inaugural Thomas J. Fogarty Prize (Fogarty Prize) for the ...

Boston Scientific (NYSE:BSX | BSX Price Prediction) stock has taken a beating in 2026 after management cut full-year guidance ...